{"id":"https://openalex.org/W2900982014","doi":"https://doi.org/10.2217/fon-2018-0546","title":"Apalutamide and its Use in the Treatment of Prostate Cancer","display_name":"Apalutamide and its Use in the Treatment of Prostate Cancer","publication_year":2018,"publication_date":"2018-11-14","ids":{"openalex":"https://openalex.org/W2900982014","doi":"https://doi.org/10.2217/fon-2018-0546","mag":"2900982014","pmid":"https://pubmed.ncbi.nlm.nih.gov/30426794","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6391625"},"language":"en","primary_location":{"id":"doi:10.2217/fon-2018-0546","doi":"https://doi.org/10.2217/fon-2018-0546","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fon-2018-0546","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6391625","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019292233","display_name":"Hala T. Borno","orcid":"https://orcid.org/0000-0002-4357-9759","observed_orcids":["https://orcid.org/0000-0002-4357-9759"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hala T Borno","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco","Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco","Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, CA94158, USA","Fax: +415 514 5835","Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA94158, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]},{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, CA94158, USA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Fax: +415 514 5835","institution_ids":[]},{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J Small","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco","Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco","Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, CA 94158, USA Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA 94158, USA","Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA94158, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]},{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, CA 94158, USA Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA 94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, Department of Medicine, University of California at San Francisco, CA94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1331,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.18001324,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"15","issue":"6","first_page":"591","last_page":"599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apalutamide","display_name":"apalutamide","score":1.0},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9419999718666077},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.8429999947547913},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.9340000152587891},{"id":"https://openalex.org/keywords/metastasis-free-survival","display_name":"metastasis-free survival","score":0.859000027179718},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.878000020980835},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.7609999775886536},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9064215421676636},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8821842670440674},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.632231593132019},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.5708816051483154},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.567071259021759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5586308240890503},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.5280041694641113},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.46716487407684326},{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.45427143573760986},{"id":"https://openalex.org/C2779322244","wikidata":"https://www.wikidata.org/wiki/Q574820","display_name":"Antiandrogen","level":4,"score":0.43929019570350647},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4356813430786133},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43505120277404785},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.4336225986480713},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1160840392112732}],"mesh":[{"descriptor_ui":"D000071066","descriptor_name":"Patient Reported Outcome Measures","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013867","descriptor_name":"Thiohydantoins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013867","descriptor_name":"Thiohydantoins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013867","descriptor_name":"Thiohydantoins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013867","descriptor_name":"Thiohydantoins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2217/fon-2018-0546","doi":"https://doi.org/10.2217/fon-2018-0546","is_oa":false,"landing_page_url":"https://doi.org/10.2217/fon-2018-0546","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6391625","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6391625","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncol","raw_type":"Text"},{"id":"pmid:30426794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30426794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6391625","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6391625","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000912066","display_name":"Research Training in Geriatric Medicine","funder_award_id":"T32AG000212","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1933794219","https://openalex.org/W1974351254","https://openalex.org/W2003955264","https://openalex.org/W2004111833","https://openalex.org/W2028387248","https://openalex.org/W2055346449","https://openalex.org/W2068997992","https://openalex.org/W2081084828","https://openalex.org/W2084637523","https://openalex.org/W2091749101","https://openalex.org/W2093941725","https://openalex.org/W2101134619","https://openalex.org/W2107270081","https://openalex.org/W2119504728","https://openalex.org/W2130189600","https://openalex.org/W2130669171","https://openalex.org/W2137467802","https://openalex.org/W2139287380","https://openalex.org/W2148643283","https://openalex.org/W2150039609","https://openalex.org/W2150402649","https://openalex.org/W2167331614","https://openalex.org/W2171041379","https://openalex.org/W2181283187","https://openalex.org/W2278392405","https://openalex.org/W2297697424","https://openalex.org/W2431521472","https://openalex.org/W2590151349","https://openalex.org/W2608651822","https://openalex.org/W2620250723","https://openalex.org/W2743350540","https://openalex.org/W2768353180","https://openalex.org/W2792086148","https://openalex.org/W2793786660","https://openalex.org/W2799328879","https://openalex.org/W2810806599","https://openalex.org/W2811470123","https://openalex.org/W2885695264","https://openalex.org/W2886092791","https://openalex.org/W2888791671","https://openalex.org/W2891576771","https://openalex.org/W2906946353","https://openalex.org/W4211197560"],"related_works":["https://openalex.org/W2788422090","https://openalex.org/W2792086148","https://openalex.org/W2898252193","https://openalex.org/W2972013902","https://openalex.org/W2966721444","https://openalex.org/W4386610921","https://openalex.org/W2793094876","https://openalex.org/W2886976964","https://openalex.org/W2962860044","https://openalex.org/W4234126223"],"abstract_inverted_index":{"High-risk":[0],"nonmetastatic":[1,37],"castration-resistant":[2,38],"prostate":[3,39],"cancer":[4],"is":[5,19,46,61,73],"a":[6,64],"lethal":[7],"disease":[8],"that":[9],"previously":[10],"lacked":[11],"clear":[12],"treatment":[13,81],"options.":[14],"Progression":[15],"to":[16,57,75,80],"bone":[17],"metastases":[18],"associated":[20,62],"with":[21,63,82],"significant":[22],"morbidity":[23],"and":[24,49,55,60],"high":[25],"cost.":[26],"Apalutamide,":[27],"an":[28],"androgen":[29,43,83],"receptor":[30],"inhibitor,":[31],"has":[32],"substantial":[33],"clinical":[34],"response":[35],"in":[36],"cancer.":[40],"Apalutamide":[41],"+":[42],"deprivation":[44],"therapy":[45],"well":[47],"tolerated":[48],"improves":[50],"metastasis-free":[51],"survival,":[52],"progression-free":[53],"survival":[54],"time":[56],"symptomatic":[58],"progression,":[59],"favorable":[65],"trend":[66],"of":[67,78],"improved":[68],"overall":[69],"survival.":[70],"Future":[71],"research":[72],"needed":[74],"elucidate":[76],"mechanisms":[77],"resistance":[79],"signaling":[84],"inhibitors.":[85]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-29T00:00:00"}